{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-007340","form_type":"8-K","ticker":"AVR","cik":"0002011514","company_name":"Anteris Technologies Global Corp.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.791586+00:00","generated_at":"2026-05-25T07:49:48.848065+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anteris Technologies appoints David St Denis as President and Class II director","bullets":["Appointment effective March 5, 2025; St Denis retains COO role and serves as CEO of v2vmedtech.","St Denis has been COO since July 2017; prior roles include Merck and Millennium Pharmaceuticals.","No material amendment to compensatory arrangements; no new grants or awards in connection.","St Denis will not sit on any Board committees due to non-independent status."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-007340","json":"https://secwatch.observer/filing/0001140361-25-007340.json","markdown":"https://secwatch.observer/filing/0001140361-25-007340.md","text":"https://secwatch.observer/filing/0001140361-25-007340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/ef20045020_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T07:49:48.848065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3396c1a4cb","claim":"David St Denis was appointed as Class II director at Anteris Technologies Global Corp..","evidence_excerpt":"On March 5, 2025 (March 6, 2025 in Australia), the Board of Directors (the “Board”) of Anteris Technologies Global Corp. (the “Company”) appointed David St Denis as the Company’s President and as a Class II director of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"},{"claim_id":"76c65f50b4","claim":"David St Denis was appointed as President at Anteris Technologies Global Corp..","evidence_excerpt":"On March 5, 2025 (March 6, 2025 in Australia), the Board of Directors (the “Board”) of Anteris Technologies Global Corp. (the “Company”) appointed David St Denis as the Company’s President and as a Class II director of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}